No Data
No Data
Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer
Express News | Janux Therapeutics Promotes Zachariah Mciver, D.o., Ph.d. to Chief Medical Officer
JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $105
Buy Rating for Janux Therapeutics Amidst Competitive Landscape and Advancements in Masked T-cell Engagers
Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
Clement Lemons : okk
章允量 :
103575541 :
RetireWise : Ho ho ho... Santa Claus is coming to town
Adrianlim90 : 1
View more comments...